AROMATASE INHIBITOR- INDUCED CHANGES IN THE LIPID PROFILE OF POSTMENOPAUSAL WOMEN WITH EARLY STAGE BREAST CANCER.

被引：0
|
作者：
Bell, L. N. [1 ]
Nguyen, A. T. [1 ]
Li, L. [1 ]
Desta, Z. [1 ]
Flockhart, D. A. [1 ]
机构：
[1] Indiana Univ, Indianapolis, IN 46204 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 50 条
  • [1] Assessment of concomitant versus sequential aromatase inhibitor with radiotherapy for postmenopausal women with early-stage breast cancer.
    El-Bary, N. M. Abd
    Hashem, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Prevalence of joint symptoms in postmenopausal women on aromatase inhibitors for early stage breast cancer.
    Crew, K. D.
    Apollo, A.
    Greenlee, H.
    Raptis, G.
    Braffman, L.
    Fuentes, D.
    Hershman, D. L.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S235 - S235
  • [3] Early discontinuation of tamoxifen and aromatase inhibitors (AIs) by postmenopausal women with early-stage breast cancer.
    Charlson, J. A.
    Hedin, T.
    Sparapani, R.
    Guo, C.
    Nattinger, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Comparison of Changes in the Lipid Profile of Postmenopausal Women With Early Stage Breast Cancer Treated With Exemestane or Letrozole
    Bell, Lauren Nicole
    Anne Thi Phuong Nguyen
    Li, Lang
    Desta, Zeruesenay
    Henry, N. Lynn
    Hayes, Daniel F.
    Wolff, Antonio C.
    Stearns, Vered
    Storniolo, Anna Maria
    Flockhart, David A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (12): : 1852 - 1860
  • [5] Changes in lipid-levels following aromatase inhibitor treatment in early postmenopausal breast cancer
    Lund, M.
    Corn, G.
    Jensen, M-B.
    Petersen, T. S.
    Dalhoff, K.
    Ejlertsen, B.
    Kober, L.
    Wohlfahrt, J.
    Melbye, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S341 - S341
  • [6] The effect of the aromatase inhibitor letrozole on lipid parameters in postmenopausal women with metastatic breast cancer. A preliminary report.
    Nicolaides, C
    Elisaf, M
    Bairaktari, E
    Kakaidi, V
    Katsaraki, A
    Pavlidis, N
    ANNALS OF ONCOLOGY, 2000, 11 : 12 - 12
  • [7] Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer
    Buzdar, Aman U.
    Coombes, R. Charles
    Goss, Paul E.
    Winer, Eric P.
    CANCER, 2008, 112 (03) : 700 - 709
  • [8] Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer
    Ligibel, Jennifer A.
    Winer, Eric P.
    WOMENS HEALTH, 2006, 2 (01) : 89 - 97
  • [9] Genetic variants & osteoporosis in postmenopausal women with early stage breast cancer.
    Kelly, Patricia
    ONCOLOGY NURSING FORUM, 2007, 34 (02) : 555 - 555
  • [10] Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer
    Kadakia, Kunal C.
    Snyder, Claire F.
    Kidwell, Kelley M.
    Seewald, Nicholas J.
    Flockhart, David A.
    Skaar, Todd C.
    Desta, Zereunesay
    Rae, James M.
    Otte, Julie L.
    Carpenter, Janet S.
    Storniolo, Anna M.
    Hayes, Daniel F.
    Stearns, Vered
    Henry, N. Lynn
    ONCOLOGIST, 2016, 21 (05) : 539 - 546
12345